FDA Inspection 1268173 — Shanghai SynTheAll Pharmaceutical Co., Ltd.
The FDA completed an inspection of Shanghai SynTheAll Pharmaceutical Co., Ltd. on Apr 25, 2025 in Jinshan District, Shaanghai. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Apr 25, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Jinshan District, Shaanghai (China)